Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 329831, 19 pages
http://dx.doi.org/10.1155/2015/329831
Research Article

Rhein Elicits In Vitro Cytotoxicity in Primary Human Liver HL-7702 Cells by Inducing Apoptosis through Mitochondria-Mediated Pathway

1Department of Clinical Pharmacy, China Pharmaceutical University, No. 24, Tong Jia Xiang, Jiangsu, Nanjing 210009, China
2Department of Pharmacology, China Pharmaceutical University, No. 24, Tong Jia Xiang, Jiangsu, Nanjing 210009, China
3Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Education, Nanjing 210009, China

Received 1 April 2015; Accepted 24 May 2015

Academic Editor: Cheorl-Ho Kim

Copyright © 2015 Guy-Armel Bounda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Zhang, Q. Q. Zhuang, and M. Z. Mei, “Effect of some drugs on plasma and liver lipoprotein lipase activities and plasma cholesterol levels in rats,” Yao Xue Xue Bao, vol. 18, no. 6, pp. 468–471, 1983. View at Google Scholar · View at Scopus
  2. P.-G. Xiao, S.-T. Xing, and L.-W. Wang, “Immunological aspects of Chinese medicinal plants as antiageing drugs,” Journal of Ethnopharmacology, vol. 38, no. 2-3, pp. 167–175, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. T. C. Kuo, J. C. Ou, J. Tsai, C. L. Wu, and C. M. Sun, “Evaluation of Chinese herbs that affect the cell-mediated immunity (II),” Journal of Chinese Medicine, vol. 7, no. 2, pp. 119–131, 1996. View at Google Scholar
  4. J. K. H. Kam, “Mutagenic activity of Ho Shao Wu (Polygonum multiflorum Thunb.),” American Journal of Chinese Medicine, vol. 9, no. 3, pp. 213–215, 1981. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Liu, Y. Liu, Z. Chao, Z. Song, C. Wang, and A. Lu, “In vitro antioxidant activities of Maillard reaction products produced in the steaming process of Polygonum multiflorum root,” Natural Product Communications, vol. 6, no. 1, pp. 55–58, 2011. View at Google Scholar · View at Scopus
  6. R. Wang, Y. Tang, B. Feng et al., “Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats,” Neuroscience, vol. 149, no. 4, pp. 739–746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. L. Zhang, L. H. Huang, L. W. Chen, D. J. Hao, and J. Z. Chen, “Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease,” Toxicology Letters, vol. 222, no. 2, pp. 155–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B.-H. Lee, Y.-Y. Huang, P.-D. Duh, and S.-C. Wu, “Hepatoprotection of emodin and Polygonum multiflorum against CCl4-induced liver injury,” Pharmaceutical Biology, vol. 50, no. 3, pp. 351–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L.-C. Lin, S. M. Nalawade, V. Mulabagal, M.-S. Yeh, and H.-S. Tsay, “Micropropagation of Polygonum multiflorum Thunb and quantitative analysis of the anthraquinones emodin and physcion formed in in vitro propagated shoots and plants,” Biological and Pharmaceutical Bulletin, vol. 26, no. 10, pp. 1467–1471, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Yi, K. S. Y. Leung, G.-H. Lu, H. Zhang, and K. Chan, “Identification and determination of the major constituents in traditional Chinese medicinal plant Polygonum multiflorum Thunb by HPLC coupled with PAD and ESI/MS,” Phytochemical Analysis, vol. 18, no. 3, pp. 181–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. J.-H. Park, S. P. Mann, and M. C. Ngu, “Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum,” Journal of Gastroenterology and Hepatology, vol. 16, no. 1, pp. 115–117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. K. A. Jung, H. J. Min, S. S. Yoo et al., “Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum thunb,” Gut and Liver, vol. 5, no. 4, pp. 493–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Dini, “Clearance of apoptotic lymphocytes by human Kupffer cells. Phagocytosis of apoptotic cells in the liver: role of lectin receptors and therapeutic advantages,” in Apoptosis and Its Modulation by Drugs, R. G. Cameron and G. Feuer, Eds., Handbook of Experimental Pharmacology, pp. 319–341, Springer, Berlin, Germany, 2000. View at Publisher · View at Google Scholar
  14. M. G. Neuman, “Apoptosis in diseases of the liver,” Critical Reviews in Clinical Laboratory Sciences, vol. 38, no. 2, pp. 109–166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Dini, L. Falasca, A. Lentini et al., “Galactose-specific receptor modulation related to the onset of apoptosis in rat liver,” European Journal of Cell Biology, vol. 61, no. 2, pp. 329–337, 1993. View at Google Scholar · View at Scopus
  16. Y. Ossawa, E. Seki, and D. A. Brenner, “Apoptosis in liver injury and liver diseases,” in Essentials of Apoptosis, Z. Dong and X. M. Yin, Eds., pp. 547–564, Humana Press, 2009. View at Google Scholar
  17. D. Schrenk, H.-J. Schmitz, S. Bohnenberger, B. Wagner, and W. Wörner, “Tumor promoters as inhibitors of apoptosis in rat hepatocytes,” Toxicology Letters, vol. 149, no. 1–3, pp. 43–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. T.-Y. Wu, C.-P. Chen, and T.-R. Jinn, “Traditional Chinese medicines and Alzheimer's disease,” Taiwanese Journal of Obstetrics and Gynecology, vol. 50, no. 2, pp. 131–135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Liu, M. W. Kong, S. H. Yuan, J. Liu, and P. Wang, “History and experience: a survey of traditional Chinese medicine treatment for Alzheimer's disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 642128, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. O'Brien, “Alternative perspectives: how Chinese medicine understands hypercholesterolemia,” Cholesterol, vol. 2010, Article ID 723289, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. F. Yang, “Herbs that tonify,” in Chinese Herbal Medicine: Comparisons and Characteristics, Y. F. Yang, Ed., pp. 157–185, Elsevier, 2nd edition, 2010. View at Google Scholar
  22. V. Scheid, D. Bensky, R. Barolet et al., “Formulas that tonify,” in Chinese Herbal Medicine: Formulas and Strategies, V. Scheid, D. Bensky, A. Ellis, and R. Barolet, Eds., pp. 307–418, Eastland Press, Seattle, Wash, USA, 2nd edition, 2009. View at Google Scholar
  23. B. Singh, J. R. Nadkarni, R. A. Vishwakarma, S. B. Bharate, M. Nivsarkar, and S. Anandjiwala, “The hydroalcoholic extract of Cassia alata (Linn.) leaves and its major compound rhein exhibits antiallergic activity via mast cell stabilization and lipoxygenase inhibition,” Journal of Ethnopharmacology, vol. 141, no. 1, pp. 469–473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. K. Agarwal, S. S. Singh, S. Verma, and S. Kumar, “Antifungal activity of anthraquinone derivatives from Rheum emodi,” Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 43–46, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Jong-Chol, M. Tsukasa, A. Kazuo, K. Hiroaki, Y. Haruki, and O. Yasuo, “Anti-Bacteroides fragilis substance from rhubarb,” Journal of Ethnopharmacology, vol. 19, no. 3, pp. 279–283, 1987. View at Publisher · View at Google Scholar · View at Scopus
  26. D. L. Barnard, J. H. Huffman, J. L. B. Morris, S. G. Wood, B. G. Hughes, and R. W. Sidwell, “Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus,” Antiviral Research, vol. 17, no. 1, pp. 63–77, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Delpino, M. G. Paggi, P. F. Gentile et al., “Protein synthetic activity and adenylate energy charge in Rhein-treated cultured human glioma cells,” Cancer Biochemistry Biophysics, vol. 12, no. 4, pp. 241–252, 1992. View at Google Scholar · View at Scopus
  28. S. Castiglione, M. Fanciulli, T. Bruno et al., “Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions,” Anti-Cancer Drugs, vol. 4, no. 3, pp. 407–414, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Lin, M. Fujii, and D.-X. Hou, “Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway,” Archives of Biochemistry and Biophysics, vol. 418, no. 2, pp. 99–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. Du, X.-L. Bian, X.-L. Xu, B. Zhu, B. Yu, and Q. Zhai, “Role of mitochondrial permeability transition in human hepatocellular carcinoma Hep-G2 cell death induced by rhein,” Fitoterapia, vol. 91, pp. 68–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Davis, “Introduction,” in Apoptosis Methods in Pharmacology and Toxicology: Approaches to Measurements and Quantitation, M. A. Davis, Ed., pp. 1–9, Humana Press, Totowa, NJ, USA, 2002. View at Google Scholar
  32. A. H. Wyllie, J. F. R. Kerr, and A. R. Currie, “Cell death: the significance of apoptosis,” International Review of Cytology, vol. 68, pp. 251–306, 1980. View at Google Scholar · View at Scopus
  33. M. D. Jacobson, M. Weil, and M. C. Raff, “Programmed cell death in animal development,” Cell, vol. 88, no. 3, pp. 347–354, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Kasof, K. Degenhardt, D. Perez, T. Anju, and E. White, “Overview: a matter of life and death,” in Signaling Pathways in Apoptosis, D. Watters and M. Lavin, Eds., pp. 1–30, Harwood Academic Publishers, Herston, Australia, 1999. View at Google Scholar
  35. S. Fulda and K.-M. Debatin, “Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy,” Oncogene, vol. 25, no. 34, pp. 4798–4811, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Kågedal, D. Bironalte, and K. Öllinger, “Anthraquinone cytotoxicity and apoptosis in primary cultures of rat hepatocytes,” Free Radical Research, vol. 31, no. 5, pp. 419–428, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. R. E. Schwartz, H. E. Fleming, S. R. Khetani, and S. N. Bhatia, “Pluripotent stem cell-derived hepatocyte-like cells,” Biotechnology Advances, vol. 32, no. 2, pp. 504–513, 2014. View at Publisher · View at Google Scholar
  38. E. L. LeCluyse, “Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation,” European Journal of Pharmaceutical Sciences, vol. 13, no. 4, pp. 343–368, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Luo, H. Zhou, F. Wang et al., “The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells,” International Journal of Oncology, vol. 42, no. 5, pp. 1636–1643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Yang, L. Chen, M.-K. Yang et al., “In vitro study of the interactions of galactosylated thermo-responsive hydrogels with cells,” Carbohydrate Polymers, vol. 88, no. 2, pp. 509–516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Hu, T. Yang, C. Li et al., “Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model,” Transplantation Proceedings, vol. 45, no. 2, pp. 695–700, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ma, Z. Z. Jiang, J. Ruan et al., “The furano norclerodane diterpenoid disobulbin-D induces apoptosis in normal human liver L-02 cells,” Experimental and Toxicologic Pathology, vol. 64, no. 6, pp. 611–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. X.-M. Chen, J. Liu, T. Wang, and J. Shang, “Colchicine-induced apoptosis in human normal liver L-02 cells by mitochondrial mediated pathways,” Toxicology in Vitro, vol. 26, no. 5, pp. 649–655, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. D.-Y. Shi, F.-Z. Xie, C. Zhai, J. S. Stern, Y. Liu, and S.-L. Liu, “The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells,” Molecular Cancer, vol. 8, article 32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Hu, H. Ma, W. Zhang, Z. Yu, G. Sheng, and J. Fu, “Effects of benzene and its metabolites on global DNA methylation in human normal hepatic L02 cells,” Environmental Toxicology, vol. 29, no. 1, pp. 108–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Cossarizza, M. Baccarani-Contri, G. Kalashnikova, and C. Franceschi, “A new method for the cytofluorometric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1),” Biochemical and Biophysical Research Communications, vol. 197, no. 1, pp. 40–45, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Fleury, B. Mignotte, and J.-L. Vayssière, “Mitochondrial reactive oxygen species in cell death signaling,” Biochimie, vol. 84, no. 2-3, pp. 131–141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Sreelatha, P. R. Padma, and M. Umadevi, “Protective effects of Coriandrum sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats,” Food and Chemical Toxicology, vol. 47, no. 4, pp. 702–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Ghosh, S. Mitra, and A. Paul, “Physiochemical studies of Sodium Chloride on Mungbean (Vigna radiate L. Wilczek) and its possible recovery with Spermine and Gibberellic Acid,” The Scientific World Journal, vol. 2015, Article ID 858016, 8 pages, 2015. View at Publisher · View at Google Scholar
  51. S. K. Powers, J. C. Quindry, and A. N. Kavazis, “Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury,” Free Radical Biology and Medicine, vol. 44, no. 2, pp. 193–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. Z.-Q. Jiang, X.-J. Yan, L. Bi, J.-P. Chen, Q. Zhou, and W.-P. Chen, “Mechanism for hepato-protective action of Liangxue Huayu Recipe (LHR): blockade of mitochondrial cytochrome c release and caspase activation,” Journal of Ethnopharmacology, vol. 148, no. 3, pp. 851–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Furukawa, S. Kasajima, Y. Nakamura et al., “Toxic hepatitis induced by Show-Wu-Pian, a Chinese herbal preparation,” Internal Medicine, vol. 49, no. 15, pp. 1537–1540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Bironaite and K. Ollinger, “The hepatotoxicity of rhein involves impairment of mitochondrial functions,” Chemico-Biological Interactions, vol. 103, no. 1, pp. 35–50, 1997. View at Publisher · View at Google Scholar · View at Scopus
  55. A. A. Mahbub, C. L. Le Maitre, S. L. Haywood-Small, G. J. McDougall, N. A. Cross, and N. Jordan-Mahy, “Differential effects of polyphenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 10, pp. 1601–1613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Rej, “Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues,” Clinical Chemistry, vol. 24, no. 11, pp. 1971–1979, 1978. View at Google Scholar · View at Scopus
  57. J. D. Y. Chow, R. T. Lawrence, M. E. Healy et al., “Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation,” Molecular Metabolism, vol. 3, no. 4, pp. 419–431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Kakisaka, S. C. Cazanave, C. D. Fingas et al., “Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 302, no. 1, pp. G77–G84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. F. R. Maxfield and I. Tabas, “Role of cholesterol and lipid organization in disease,” Nature, vol. 438, no. 7068, pp. 612–621, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. E. P. Beltroy, J. A. Richardson, J. D. Horton, S. D. Turley, and J. M. Dietschy, “Cholesterol accumulation and liver cell death in mice with Niemann-Pick type C disease,” Hepatology, vol. 42, no. 4, pp. 886–893, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Tsukamoto, H. She, S. Hazra, J. Cheng, and J. Wang, “Fat paradox of steatohepatitis,” Journal of Gastroenterology and Hepatology, vol. 23, supplement 1, pp. S104–S107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. D. F. Calvisi, C. Wang, C. Ho et al., “Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma,” Gastroenterology, vol. 140, no. 3, pp. 1071–1083, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Yahagi, H. Shimano, K. Hasegawa et al., “Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma,” European Journal of Cancer, vol. 41, no. 9, pp. 1316–1322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. C. A. Nagle, J. An, M. Shiota et al., “Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance,” Journal of Biological Chemistry, vol. 282, no. 20, pp. 14807–14815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. K. R. Feingold, M. H. Wiley, A. H. Moser, and M. D. Siperstein, “Altered activation state of hydroxymethylglutaryl-coenzyme A reductase in liver tumors,” Archives of Biochemistry and Biophysics, vol. 226, no. 1, pp. 231–241, 1983. View at Publisher · View at Google Scholar · View at Scopus
  66. N. Li, Z. Chen, X. Mao, J. Yu, and R. Zhao, “Effects of lipid regulation using raw and processed radix polygoni multiflori in rats fed a high-fat diet,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 329171, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. W. Wang, Y. He, P. Lin et al., “In vitro effects of active components of Polygonum multiflorum radix on enzymes involved in the lipid metabolism,” Journal of Ethnopharmacology, vol. 153, no. 3, pp. 763–770, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Desagher and J.-C. Martinou, “Mitochondria as the central control point of apoptosis,” Trends in Cell Biology, vol. 10, no. 9, pp. 369–377, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Hatefi, “The mitochondrial electron transport and oxidative phosphorylation system,” Annual Review of Biochemistry, vol. 54, pp. 1015–1069, 1985. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Ott, J. D. Robertson, V. Gogvadze, B. Zhivotovsky, and S. Orrenius, “Cytochrome c release from mitochondria proceeds by a two-step process,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 3, pp. 1259–1263, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Ott, V. Gogvadze, S. Orrenius, and B. Zhivotovsky, “Mitochondria, oxidative stress and cell death,” Apoptosis, vol. 12, no. 5, pp. 913–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. H. L. Xu, X. F. Yu, S. C. Qu, X. R. Qu, Y. F. Jiang, and D. Y. Sui, “Juglone, from Juglans mandshruica Maxim, inhibits growth and induces apoptosis in human leukemia cell HL-60 through a reactive oxygen species-dependent mechanism,” Food and Chemical Toxicology, vol. 50, no. 3-4, pp. 590–596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Raza, A. John, and S. Benedict, “Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells,” European Journal of Pharmacology, vol. 668, no. 1-2, pp. 15–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Wiseman and B. Halliwell, “Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer,” Biochemical Journal, vol. 313, no. 1, pp. 17–29, 1996. View at Google Scholar · View at Scopus
  75. H. Fang, Y. Wu, J. Guo et al., “T-2 toxin induces apoptosis in differentiated murine embryonic stem cells through reactive oxygen species-mediated mitochondrial pathway,” Apoptosis, vol. 17, no. 8, pp. 895–907, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Goel, V. Dani, and D. K. Dhawan, “Protective effects of zinc on lipid peroxidation, antioxidant enzymes and hepatic histoarchitecture in chlorpyrifos-induced toxicity,” Chemico-Biological Interactions, vol. 156, no. 2-3, pp. 131–140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. A.-G. Wang, T. Xia, Q.-L. Chu et al., “Effects of fluoride on lipid peroxidation, DNA damage and apoptosis in human embryo hepatocytes,” Biomedical and Environmental Sciences, vol. 17, no. 2, pp. 217–222, 2004. View at Google Scholar · View at Scopus
  78. Y. Y. Ye, J. W. Liu, J. H. Xu, L. J. Sun, M. C. Chen, and M. B. Lan, “Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line,” Toxicology in Vitro, vol. 24, no. 3, pp. 751–758, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Sha, W. Gao, S. Wang, F. Xu, and T. Lu, “Cytotoxicity of titanium dioxide nanoparticles differs in four liver cells from human and rat,” Composites Part B: Engineering, vol. 42, no. 8, pp. 2136–2144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. N. P. Gomes and J. M. Espinosa, “Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding,” Genes and Development, vol. 24, no. 10, pp. 1022–1034, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. J. R. Jeffers, E. Parganas, Y. Lee et al., “Puma is an essential mediator of p53-dependent and -independent apoptotic pathways,” Cancer Cell, vol. 4, no. 4, pp. 321–328, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. W. W. Tsai and M. C. Barton, “p53,” in Signaling Pathways in Liver Diseases, J. F. Durfour and P. A. Clavien, Eds., pp. 345–357, Springer, Berlin, Germany, 2nd edition, 2010. View at Publisher · View at Google Scholar
  83. E. A. Slee, M. T. Harte, R. M. Kluck et al., “Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2,-3,-6,-7,-8, and -10 in a caspase-9-dependent manner,” Journal of Cell Biology, vol. 144, no. 2, pp. 281–292, 1999. View at Publisher · View at Google Scholar · View at Scopus
  84. G.-C. Lee, J. H. Lee, B. Y. Kim, and C. H. Lee, “Mitochondria-targeted apoptosis in human cytomegalovirus-infected cells,” Journal of Microbiology and Biotechnology, vol. 23, no. 11, pp. 1627–1635, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Peng, J.-G. Sun, and G.-J. Wang, “Pharmacokinetic study of rhein and its carboxyl-esterification derivatives in rats,” Chinese Journal of Natural Medicines, vol. 7, no. 3, pp. 228–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. M.-L. Hou, L.-W. Chang, C.-H. Lin, L.-C. Lin, and T.-H. Tsai, “Determination of bioactive components in Chinese herbal formulae and pharmacokinetics of Rhein in rats by UPLC-MS/MS,” Molecules, vol. 19, no. 4, pp. 4058–4075, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. K. Hao, Q. Qi, P. Wan et al., “Prediction of human pharmacokinetics from preclinical information of rhein, an antidiabetic nephropathy drug, using a physiologically based pharmacokinetic model,” Basic & Clinical Pharmacology & Toxicology, vol. 114, no. 2, pp. 160–167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” The FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER), Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers, U.S. Food and Drug Administration, Rockville, Md, USA, 2002.
  90. L. Tan, Y. S. Yuan, J. W. Yang, and Q. Qiu, “Determination of rhein in human plasma by HPLC and the study of its pharmacokinetics,” Bulletin of Jinling Hospital, vol. 11, pp. 112–115, 1998. View at Google Scholar
  91. W. Zhu, X.-M. Wang, L. Zhang, X.-Y. Li, and B.-X. Wang, “Pharmacokinetic of Rhein in healthy male volunteers following oral and retention enema administration of rhubarb extract: a single dose study,” The American Journal of Chinese Medicine, vol. 33, no. 6, pp. 839–850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. J.-Y. Jiang, M.-W. Yang, W. Qian et al., “Quantitative determination of rhein in human plasma by liquid chromatography-negative electrospray ionization tandem mass/mass spectrometry and the application in a pharmacokinetic study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 57, no. 1, pp. 19–25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. Pharmacopoeia of the People's Republic of China, First Division, China Chemical Industry Press, Beijing, China, 2010.